Europe Eye Drops Market Forecast to 2030

Europe Eye Drops Market Forecast to 2030 – Regional Analysis – by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application {Eye Diseases (Dry Eye, Glaucoma, Cataract, and Others), Eye Care, and Others}, and Purchase Mode (OTC and Prescription)

Send Enquiry

$2,100$3,500

Description

The Europe eye drops market is expected to grow from US$ 3,496.63 million in 2022 to US$ 5,093.11 million by 2030. It is estimated to grow at a CAGR of 4.8% from 2022 to 2030.

High Incidence of Age-Related Eye Diseases Fuels Europe Eye Drops Market

Weakening of eye vision is prominently caused by aging. According to the World Health Organization’s World Vision Report, with an aging global population, vision impairment has risen to the forefront as a significant public health concern. In 2020, 11 billion people had uncorrected presbyopia or distance vision impairment. This amount is predicted to rise to 18 billion by 2050. Cataracts, age-related macular degeneration, glaucoma, diabetic retinopathy, and presbyopia are common causes of vision impairment that occur more frequently in later life (>60 years). Although, over the last 30 years, the age-standardized prevalence of vision impairment and blindness has reduced, this decrease has been offset by a rapidly aging population, resulting in a surging number of individuals with blindness and vision impairment globally, primarily adults over the age of 60. Thus, the high prevalence of eye disease among the older population is likely to encourage manufacturers to introduce new eye care products in the market, which, in turn, will contribute to the growth of the market. Also, the development in the healthcare industry has increased life expectancy. Various healthcare companies design products focusing on the geriatric population. Countries worldwide are adopting new techniques to treat older people safely and effectively. Thus, the growing aging population is driving the growth of the market.

Europe Eye Drops Market Overview

The Europe eye drops market in Europe is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the Europe eye drops market. The market growth in this region is attributed to the growing presence of various domestic players across European countries and the increasing prevalence of dry eye disease. Numerous people in Germany are living with eye disorders. Also, the incidence of dry eye condition is increasing among the elderly population in the country. Glaucoma is another leading factor causing dry eye condition among masses. Germany records a widespread occurrence of ophthalmic conditions such as glaucoma, cataracts, and retinal detachments. According to the article “Incidence of Retinal Detachment in Germany: Results from the Gutenberg Health Study,” published in the Ophthalmological Journal in May 2021, the incidence rate of retinal detachment disease in Germany was 42 per 100,000 people per year for the age group of 35–74 years. Compared to estimates from other European nations, the study projected that Germany has a higher incidence of retinal detachment in this age group.
As per the Federal Statistical Office (Destatis), ~16.2 million people in Germany were age 67 and above by the end of 2021, and the number is projected to rise to 21.6 million by 2060. Furthermore, illnesses and eyesight problems are more common among elderly people. The incidence of eye-related disease is expected to increase with the rising aging population in Germany in the coming years, thus fueling the growth of the Europe eye drops market in the country.

Europe Eye Drops Market Revenue and Forecast to 2030 (US$ Million)

Europe Eye Drops Market Segmentation

The Europe eye drops market is segmented into type, application, purchase mode, and country.
Based on type, the Europe eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the Europe eye drops market in 2022.

Based on application, the Europe eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the Europe eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.

Based on purchase mode, the Europe eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the Europe eye drops market in 2022.

Based on country, the Europe eye drops market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe eye drops market in 2022.
AbbVie Inc, Akorn Operating Company LLC, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, Prestige Consumer Healthcare Inc., Rohto Pharmaceutical Co Ltd, Sager Pharma Kft., and Similasan Corp are some of the leading companies operating in the Europe eye drops market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 4.8% CAGR, the Europe Eye Drops Market is speculated to be worth US$ 5,093.11 million by 2030, says the research team

According to the research team Research, the Europe eye drops market was valued at US$ 3,496.63 million in 2022 and is expected to reach US$ 5,093.11 million by 2030, registering a CAGR of 4.8% from 2022 to 2030. Rising prevalence of ophthalmic diseases and high incidence of age-related eye diseases are the critical factors attributed to the Europe eye drops market expansion.

In recent years, various measures and efforts have been taken to create awareness and educate people regarding eye diseases, prompting patients to access suitable medications and treatments.
In 2019, the WHO launched the Universal Health Coverage and Eye Care: Promoting Country Action, an event to provide practical, step-by-step guidance to support Member States of WHO in planning and implementing the recommendations of the WHO’s World Report on vision. The WHO launched this event to provide integrated people-centered eye care services.
The Karolinska Institutet, Sweden, offers grants to promote research on eye diseases. In 2020, the institute announced US$ 5,912.88–17,738.64 (SEK 50,000–150,000) per person funding for new research projects on eye diseases. Thus, increasing funds for eyecare research will likely offer growth opportunities to the eye drop market players.
On the contrary, product recalls hamper the Europe eye drops market.

Based on type, the Europe eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held 38.6% share of Europe eye drops market in 2022, amassing US$ 1,348.87 million. It is projected to garner US$ 2,002.72 million by 2030 to expand at 5.1% CAGR during 2022–2030.

Based on application, the Europe eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held 64.1% share of Europe eye drops market in 2022, amassing US$ 2,242.17 million. It is projected to garner US$ 3,234.89 million by 2030 to expand at 4.7% CAGR during 2022–2030. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.

Based on purchase mode, the Europe eye drops market is segmented into OTC and prescription. The prescription segment held 64.0% share of Europe eye drops market in 2022, amassing US$ 2,237.55 million. It is projected to garner US$ 3,330.91 million by 2030 to expand at 5.1% CAGR during 2022–2030.

Based on country, the Europe eye drops market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 24.7% share of Europe eye drops market in 2022. It was assessed at US$ 863.93 million in 2022 and is likely to hit US$ 1,284.48 million by 2030, exhibiting a CAGR of 5.1% during 2022–2030.
Key players operating in the Europe eye drops market are AbbVie Inc, Akorn Operating Company LLC, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, Prestige Consumer Healthcare Inc., Rohto Pharmaceutical Co Ltd, Sager Pharma Kft., and Similasan Corp, among others.
In July 2023, Bausch + Lomb Corporation acquired the Blink product line of eye and contact lens drops from Johnson & Johnson Vision. The strategic acquisition is the latest example of the company’s commitment to increasing over the counter (OTC) consumer convenience in eye care.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Eye Drops Market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Eye Drops Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Pipeline Analysis
5. Europe Eye Drops Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Ophthalmic Diseases
5.1.2 High Incidence of Age-Related Eye Diseases
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Rising Initiatives for Eye Care
5.4 Future Trends
5.4.1 Changing Lifestyle
5.5 Impact Analysis
6. Eye Drops Market – Europe Market Analysis
6.1 Europe Eye Drops Market Revenue (US$ Mn), 2022 – 2030
7. Europe Eye Drops Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 Europe Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Antibiotics
7.3.1 Overview
7.3.2 Antibiotics: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Artificial Tears
7.4.1 Overview
7.4.2 Artificial Tears: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Hormones
7.5.1 Overview
7.5.2 Hormones: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Eye Drops Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Europe Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Eye Diseases
8.3.1 Overview
8.3.2 Eye Diseases: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Dry Eye
8.3.2.1.1 Overview
8.3.2.2 Dry Eye: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.3 Glaucoma
8.3.2.3.1 Overview
8.3.2.3.2 Glaucoma: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.4 Cataract
8.3.2.4.1 Overview
8.3.2.4.2 Cataract: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.5 Others
8.3.2.5.1 Overview
8.3.2.5.2 Others: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Eye Care
8.4.1 Overview
8.4.2 Eye Care: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Eye Drops Market – Revenue and Forecast to 2030 – by Purchase Mode
9.1 Overview
9.2 Europe Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
9.3 Prescription
9.3.1 Overview
9.3.2 Prescription: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
9.4 OTC
9.4.1 Overview
9.4.2 OTC: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Eye Drops Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Europe Eye Drops Market
10.1.1 Overview
10.1.2 Europe Eye Drops Market, by Country, 2022 & 2030 (%)
10.1.2.1 Germany: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 Germany: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 Germany: Europe Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.1.4 Germany: Europe Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.1.4.1 Germany: Europe Eye Drops Market, For Eye Diseases by Application, 2020–2030 (US$ Million)
10.1.2.1.5 Germany: Europe Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.2 France: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 France: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 France: Europe Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.2.4 France: Europe Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.2.4.1 France: Europe Eye Drops Market, For Eye Diseases by Application, 2020–2030 (US$ Million)
10.1.2.2.5 France: Europe Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.3 UK: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 UK: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 UK: Europe Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.3.4 UK: Europe Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.3.4.1 UK: Europe Eye Drops Market, For Eye Diseases by Application, 2020–2030 (US$ Million)
10.1.2.3.5 UK: Europe Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.4 Italy: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Italy: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.3 Italy: Europe Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.4.4 Italy: Europe Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.4.4.1 Italy: Europe Eye Drops Market, For Antibiotics by Application, 2020–2030 (US$ Million)
10.1.2.4.5 Italy: Europe Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.5 Spain: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 Spain: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.3 Spain: Europe Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.5.4 Spain: Europe Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.5.4.1 Spain: Europe Eye Drops Market, For Eye Diseases by Application, 2020–2030 (US$ Million)
10.1.2.5.5 Spain: Europe Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.2.6 Rest of Europe: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Europe: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.6.3 Rest of Europe: Europe Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.2.6.4 Rest of Europe: Europe Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.2.6.4.1 Rest of Europe: Europe Eye Drops Market, For Eye Diseases by Application, 2020–2030 (US$ Million)
10.1.2.6.5 Rest of Europe: Europe Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
11. Europe Eye Drops Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Eye Drops Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Alcon AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pfizer Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Prestige Consumer Healthcare Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Rohto Pharmaceutical Co Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 AbbVie Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bausch & Lomb Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Biomedica Pvt Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Sager Pharma Kft
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Similasan Corp
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1.             Europe Eye Drops Market Segmentation
Table 2.             Germany: Europe Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 3.             Germany: Europe Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 4.             Germany: Europe Eye Drops Market, For Eye Diseases by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5.             Germany: Europe Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 6.             France: Europe Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 7.             France: Europe Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 8.             France: Europe Eye Drops Market, For Eye Diseases by Application – Revenue and Forecast to 2030 (US$ Million)
Table 9.             France: Europe Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 10.          UK: Europe Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 11.          UK: Europe Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12.          UK: Europe Eye Drops Market, For Eye Diseases by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13.          UK: Europe Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 14.          Italy: Europe Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 15.          Italy: Europe Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16.          Italy: Europe Eye Drops Market, For Eye Diseases by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17.          Italy: Europe Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 18.          Spain: Europe Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 19.          Spain: Europe Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 20.          Spain: Europe Eye Drops Market, For Eye Diseases by Application – Revenue and Forecast to 2030 (US$ Million)
Table 21.          Spain: Europe Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 22.          Rest of Europe: Europe Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 23.          Rest of Europe: Europe Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 24.          Rest of Europe: Europe Eye Drops Market, For Eye Diseases by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25.          Rest of Europe: Europe Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 26.          Organic Developments in the Eye Drops Market
Table 27.          Inorganic Developments in the Eye Drops Market
Table 28.          Glossary of Terms, Europe Eye Drops Market
 
 

LIST OF FIGURES

Figure 1.           Europe Eye Drops Market Segmentation, By Country
Figure 2.           Europe – PEST Analysis
Figure 3.           Pipeline Analysis
Figure 4.           Europe Eye Drops Market: Key Industry Dynamics
Figure 5.           Europe Eye Drops Market: Impact Analysis of Drivers and Restraints
Figure 6.           Europe Eye Drops Market Revenue (US$ Mn), 2020 – 2030
Figure 7.           Europe Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
Figure 8.           Antibiotics: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9.           Artificial Tears: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10.        Hormones: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11.        Others: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12.        Europe Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
Figure 13.        Eye Diseases: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14.        Dry Eye: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15.        Glaucoma: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16.        Cataract: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17.        Others: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18.        Eye Care: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19.        Others: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20.        Europe Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
Figure 21.        Prescription: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22.        OTC: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23.        Europe Eye Drops Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24.        Europe Eye Drops Market, by Country, 2022 & 2030 (%)
Figure 25.        Germany: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26.        France: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27.        UK: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28.        Italy: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29.        Spain: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30.        Rest of Europe: Europe Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31.        Growth Strategies in the Eye Drops Market (%)

List of Companies

o AbbVie Inc                                                              
o Akorn Operating Company LLC                         
o Alcon AG                                                                
o Bausch & Lomb Inc                                                
o Pfizer Inc                                                                
o Prestige Consumer Healthcare Inc.                   
o Rohto Pharmaceutical Co Ltd                             
o Sager Pharma Kft                                                   
o Similasan Corp                                                       

Reviews

There are no reviews yet.

Be the first to review “Europe Eye Drops Market Forecast to 2030”